EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Distinct spatial contributions of amyloid pathology and cerebral small vessel disease to hippocampal morphology

Kristiana Xhima iD, Julie Ottoy, Erin Gibson, Katherine Zukotynski, Christopher Scott, Ginelle J Feliciano, Sabrina Adamo, Phillip H Kuo, Michael J Borrie, Howard Chertkow, Richard Frayne, Robert Laforce und 12 weitere

Alzheimer's & Dementia · 2024-05 · 20 (5) · 3687-3695

DOI: 10.1002/alz.13791 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 04.04.2024. Verfasst von Kristiana Xhima und 23 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Sandra E. Black Centre for Brain Resilience and Recovery, LC Campbell Cognitive Neurology, Hurvitz Brain Sciences Program, Sunnybrook Research In…. Hauptthemen laut MEDLINE: Hippocampus, Cerebral Small Vessel Diseases, Positron-Emission Tomography, Alzheimer Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, NIA NIH HHS, L.C. Campbell Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Cerebral small vessel disease (SVD) and amyloid beta (Aβ) pathology frequently co‐exist. The impact of concurrent pathology on the pattern of hippocampal atrophy, a key substrate of memory impacted early and extensively in dementia, remains poorly understood. METHODS In a unique cohort of mixed Alzheimer's disease and moderate–severe SVD, we examined whether total and regional neuroimaging measures of SVD, white matter hyperintensities (WMH), and Aβ, as assessed by 18 F‐AV45 positron emission tomography, exert additive or synergistic effects on hippocampal volume and shape. RESULTS Frontal WMH, occipital WMH, and Aβ were independently associated with smaller hippocampal volume. Frontal WMH had a spatially distinct impact on hippocampal shape relative to Aβ. In contrast, hippocampal shape alterations associated with occipital WMH spatially overlapped with Aβ‐vulnerable subregions. DISCUSSION Hippocampal degeneration is differentially sensitive to SVD and Aβ pathology. The pattern of hippocampal atrophy could serve as a disease‐specific biomarker, and thus guide clinical diagnosis and individualized treatment strategies for mixed dementia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HippocampusCerebral Small Vessel DiseasesPositron-Emission TomographyAlzheimer DiseaseAmyloid beta-PeptidesHumansMaleAgedFemaleWhite MatterAtrophyMagnetic Resonance ImagingAged, 80 and overNeuroimagingCohort Studies

Stichwörter der Autor:innen

Alzheimer's diseaseMedical Imaging Trials Network of Canada C6 Projectamyloidbiomarkercerebral small vessel diseasehippocampal shapehippocampal volumemixed dementianeurodegenerationvascularwhite matter hyperintensities

Substanzen

Amyloid beta-Peptides

Autor:innen und Institutionen

  • Dr. Sandra E. Black Centre for Brain Resilience and Recovery, LC Campbell Cognitive Neurology, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
  • Departments of Medicine and Radiology, McMaster University, Hamilton, Ontario, Canada.
  • Department of Medical Imaging, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
  • Departments of Medical Imaging, Medicine, Biomedical Engineering, University of Arizona, Tucson, Arizona, USA.
  • Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
  • Rotman Research Institute, Baycrest Health Sciences, Toronto, Ontario, Canada.

ORCID-Profile: Kristiana Xhima, Joel Ramirez

Förderung

  • CIHR
  • NIA NIH HHS
  • L.C. Campbell Foundation
  • Dr. Sandra Black Centre for Brain Resilience and Recovery
  • Medical Imaging Trial Network of Canada
  • ADNI Department of Defense
  • Canadian Institutes of Health Research

Zitieren

APA

Xhima, K., Ottoy, J., Gibson, E., Zukotynski, K., Scott, C., Feliciano, G. J., Adamo, S., Kuo, P. H., Borrie, M. J., Chertkow, H., Frayne, R., Laforce, R., Noseworthy, M. D., Prato, F. S., Sahlas, D. J., Smith, E. E., Sossi, V., Thiel, A., Soucy, J. P., …, & Medical Imaging Trials Network of Canada (MITNEC) (2024). Distinct spatial contributions of amyloid pathology and cerebral small vessel disease to hippocampal morphology. Alzheimer's & Dementia, 20(5), 3687-3695. https://doi.org/10.1002/alz.13791

Vancouver

Xhima K, Ottoy J, Gibson E, Zukotynski K, Scott C, Feliciano GJ, et al. Distinct spatial contributions of amyloid pathology and cerebral small vessel disease to hippocampal morphology. Alzheimer's & Dementia. 2024;20(5):3687-3695. doi:10.1002/alz.13791

BibTeX
@article{Xhima2024,
  author = {Xhima, Kristiana and Ottoy, Julie and Gibson, Erin and Zukotynski, Katherine and Scott, Christopher and Feliciano, Ginelle J and Adamo, Sabrina and Kuo, Phillip H and Borrie, Michael J and Chertkow, Howard and Frayne, Richard and Laforce, Robert and Noseworthy, Michael D and Prato, Frank S and Sahlas, Demetrios J and Smith, Eric E and Sossi, Vesna and Thiel, Alexander and Soucy, Jean-Paul and Tardif, Jean-Claude and Goubran, Maged and Black, Sandra E and Ramirez, Joel and Medical Imaging Trials Network of Canada (MITNEC), Medical Imaging Trials Network of Canada (MITNEC)},
  title = {Distinct spatial contributions of amyloid pathology and cerebral small vessel disease to hippocampal morphology},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  volume = {20},
  number = {5},
  pages = {3687--3695},
  doi = {10.1002/alz.13791}
}
Kostenlos starten →